Duration of immunity in healthy adult volunteers who completed study 6108A1-500
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2009
At a glance
- Drugs PF 5212366 (Primary) ; Hepatitis A-hepatitis B vaccine
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
- Sponsors Wyeth
- 18 Sep 2009 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
- 18 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2008 The expected completion date for this trial is now 1 Jan 2008.